Cereno Scientific announced that Eva Jagenheim is appointed Chief Financial Officer (CFO). Jagenheim has broad experience in finance and the Swedish biotech sector. She will join the company on August 28, 2023.

Eva Jagenheim, born 1966, has an M.Sc. in Business and Economics from Växjö University and an MBA from Gothenburg Business School. She has a broad experience of various roles within finance.

Previous experience includes working as an accountant at PWC, consultant at the accounting firm Arthur Andersen, and at companies of varying sizes across several different industries. She most recently work as CFO at RLS Global, a medtech company listed on Nasdaq First North Growth Market.